Publications Jan Deussing
Journal Article (13)
1.
Journal Article
8, 107 (2018)
Inferior olive CRF plays a role in motor performance under challenging conditions. TRANSLATIONAL PSYCHIATRY 2.
Journal Article
12, 67 (2018)
Chronic Stress Reduces Nectin-1 mRNA Levels and Disrupts Dendritic Spine Plasticity in the Adult Mouse Perirhinal Cortex. FRONTIERS IN CELLULAR NEUROSCIENCE 3.
Journal Article
169, pp. 374 - 382 (2018)
Mn2+ dynamics in manganese-enhanced MRI (MEMRI): Cav1.2 channel-mediated uptake and preferential accumulation in projection terminals. NEUROIMAGE 4.
Journal Article
43 (9), pp. 1943 - 1953 (2018)
NPTX2 is a key component in the regulation of anxiety. NEUROPSYCHOPHARMACOLOGY 5.
Journal Article
11 (1), pp. 4 - 31 (2018)
The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response. CURRENT MOLECULAR PHARMACOLOGY 6.
Journal Article
21 (6), pp. 803 - 807 (2018)
Chronic CRH depletion from GABAergic, long-range projection neurons in the extended amygdala reduces dopamine release and increases anxiety. NATURE NEUROSCIENCE 7.
Journal Article
23 (3), pp. 533 - 543 (2018)
Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. MOLECULAR PSYCHIATRY 8.
Journal Article
24 (9), pp. 736 - 747 (2018)
P2X7 Receptor: A Potential Therapeutic Target for Depression? TRENDS IN MOLECULAR MEDICINE 9.
Journal Article
99 (2), pp. 389 - 403 (2018)
The Role of m6A/m-RNA Methylation in Stress Response Regulation. NEURON 10.
Journal Article
38 (30), pp. 6751 - 6765 (2018)
Cerebellar Learning Properties Are Modulated by the CRF Receptor. JOURNAL OF NEUROSCIENCE 11.
Journal Article
11, 305 (2018)
Deciphering the Contributions of CRH Receptors in the Brain and Pituitary to Stress-Induced Inhibition of the Reproductive Axis. FRONTIERS IN MOLECULAR NEUROSCIENCE 12.
Journal Article
10, 436 (2018)
Disturbed Processing of Contextual Information in HCN3 Channel Deficient Mice. FRONTIERS IN MOLECULAR NEUROSCIENCE 13.
Journal Article
233 (12), pp. 9620 - 9628 (2018)
P2Y12 shRNA treatment decreases SGC activation to relieve diabetic neuropathic pain in type 2 diabetes mellitus rats. JOURNAL OF CELLULAR PHYSIOLOGY